INTRODUCTION
Episodic ataxias (EAs) are rare dominantly inherited neurological disorders characterized by recurrent episodes of imbalance and a lack of coordination lasting minutes to hours and eventually, in later stages of the disease, by neurological signs or progressive cerebellar dysfunction between the episodes. So far 8 subtypes of EAs have been described 1 . The most common subtype is EA type 2 (EA2) caused by pathogenic variants of calcium voltagegated channel subunit alpha1 A gene (CACNA1A) on chromosome 19p13 (ref. 2 ). We describe a three-generation family with four members affected by EA2 with a novel missense variant of CACNA1A.
SUBJECTS AND METHODS
A Slovak three-generation family were examined at the Department of Neurology, Faculty Hospital in Nitra, Slovakia between the years 2014 and 2016. Due to the typical history of recurrent episodes of ataxia, clinical findings, and exclusion of other differential diagnoses, we suspected EA2 in four family members (Fig.1) . Clinical neurological examinations and genetic blood tests were performed in the patients and other healthy family mem- -III) give the generation, arabic numerals (1-3) the individuals within one generation. Square -male, circle -female, filled symbol -affected subject, blank symbol -unaffected subject, diagonal line -deceased subject.
bers after obtaining their written informed consent. The Ethics committee of Jessenius Faculty of Medicine at Comenius University (Slovakia) approved the study. Written informed consent was obtained from the family members.
DNA was extracted from peripheral blood using standard procedures, all according to the manufac- 3, 4 .
RESULTS
A 21-year-old man (III-1) reported recurrent attacks of severe gait instability with vertigo, nausea, vomiting, sensation of heat in the body, and dysarthria provoked by stress. The duration of the ataxic episodes usually ranged from 5 to 24 h. Relapses began at the age of 3 occurring 3 times a week. A neurological examination showed persistent symmetric gaze-evoked horizontal nystagmus and mild mental retardation (IQ = 75). The patient reported no progressive neurological symptoms. He suffered from migraine with visual aura occurring 5 times a month. Brain MRI revealed a mild frontal atrophy. Prescription of acetazolamide led to suppression of the ataxic episodes and amelioration of migraine. Genetic analysis with direct sequencing revealed a novel heterozygous CACNA1A (ENST00000360228) variant c.5264A>G. Codon GAA coding for glutamic acid (Glu) at position 1755 was substituted in one allele by codon GGA for glycine (Gly). The variant resulting in p.Glu1755Gly (ENSP00000353362) was evaluated with the prediction tool PolyPhen-2 as "probably damaging" with a score of 1.0, and with MutationTaster as "disease causing" with probability 1.0.
His 53-year-old mother (II-3) suffered from recurrent episodes of ataxia, nystagmus, dysarthria, and triptanunresponsive migraine with visual aura starting at the age of 17. The episodes lasted 12-24 h, occurring once a week. An interictal neurological examination revealed only mild cognitive deficit. No neurological progression was present. Brain MRI was normal. She began treatment with acetazolamide 3 times a day (500-250-250 mg) and reported a decrease in severity and frequency of ataxia and migraine attacks. A genetic analysis of CACNA1A revealed the same novel variant p.Glu1755Gly.
A 46-year-old man (uncle, II-1) reported a history of reccurrent episodes of ataxia, vertigo, nausea, and sensation of heat starting at the age of 13 (once a month). The duration of the ataxic episodes usually ranged from 5 to 48 h. A neurological examination revealed mild cognitive deficit, horizontal gaze-evoked nystagmus, bilateral neocerebellar and paleocerebellar syndrome, and spastic quadruparesis with spastic-ataxic gait of moderate severity and need of crutches. The progressive neurological disability had developed over the past ten years. Brain MRI revealed a mild cerebellar atrophy. He underwent complex differential diagnosis which ruled out other diseases (including spinocerebellar ataxias 1,2,3,6; based on genetic analysis). Analysis of CACNA1A revealed the same novel variant p.Glu1755Gly.
The fourth affected family member was a grandmother (I-2). Unfortunately, she unexpectedly died when she was 70 years old, before we could examine her. She suffered from recurrent relapses of vertigo, gait and postural instability, and dysarthria. We do not have reliable information about the duration or frequency of ataxia episodes. She was never examined for EA2 or treated with acetazolamide.
In the rest of the family (II-2,II-4,III-2), neurological findings were normal. Genetic analyses did not reveal the variant of CACNA1A in healthy family members. However they reported epilepsy (II-2), headache (II-2,II-5), and sudden death due to hemorrhagic stroke (II-5).
DISCUSSION
EA2, the most common subtype of EAs, is caused by pathogenic CACNA1A variants. CACNA1A encodes the pore-forming and voltage-sensing alpha-1A subunit of the voltage-dependent P/Q-type calcium channel (Ca v 2.1). It is expressed throughout the central nervous system, particularly in cerebellar Purkinje and granule cells, as well as at neuromuscular junctions 5, 6 . CACNA1A variants are associated with several dominantly inherited disorders with episodic or progressive neurological symptoms, such as EA2 (MIM#108500), familial hemiplegic migraine type 1 (FHM1, MIM#141500) (ref. 7 ), spinocerebellar ataxia type 6 (SCA6, MIM#183086) (ref. 8 ), epilepsy 9 , and myasthenic syndrome 10 . Alpha-1A subunit is a protein which consists of about 2500 amino acids. Amino-acid sequence is organized in four domains (I-IV), each containing six transmembrane segments (S1-S6) and a membraneassociated loop between S5 and S6 segments 11 . S4 segments serve as voltage sensors that activate and initiate a conformational change that opens the channel pore. S5 and S6 segments and the membrane-associated pore loop between them form the lining of the voltage-gated calcium channel. Selectivity and permeability are achieved by interaction of calcium ions with high-affinity binding sites in these pore loops 11 . We describe a family affected by EA2 with a novel point variant of the CACNA1A found in four members of a three-generation family. So far more than 60 variants of CACNA1A (nonsense, missense, as well as CAGtriplet expansions) have been identified and associated with EA2 (ref. 12 ). Several missense variants in pore-loop regions have been described in the medical literature so far [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . Structural changes in pore-loop regions can lead to functional changes disabling activation or inactivation of calcium flux 16 . Our heterozygous missense p.Glu1755Gly variant resulted in negatively charged glutamic acid being substituted with hydrophobic uncharged glycine within the pore loop of domain IV. Glutamic acid at codon 1755 is a highly conserved amino acid from drosophila to man. Denier et al. described a family with a different missense variant at the same position (at position 1755): glutamic acid (Glu) was substituted for lysine (Lys) (ref. 21 ). Comparision of both phenotypes is in the Table 1 . Both families (Denier's and ours) suffered from episodes of ataxia in combination with dysarthria, vertigo, nausea/ vomitus, and sensations of heat. Only some members of both families suffered from progressive ataxia and interictal oculomotor dysfunction. Progressive neurological dysability in our affected family member was more severe compared to Denier's family (moderate spastic-ataxic gait vs. mild ataxia). Our patients suffer from migraine with visual aura. The variant in Denier's family led to later onset of symptoms and shorter duration of ataxic episodes compared to our family (30-40 vs. 3-17 years and 0.5-4 vs. 5-48 h, respectively). Acetazolamide, which presumably stabilizes mutant calcium channels that fail to properly inactivate by decreasing pH, was effective in both variants 16, 25 . A small number of subjects and no functional study are the main limitations of our study. However, the functional relevance of the new variant is strongly supported by its presence only in the clinically affected members of the family; by its damaging impact predicted by two different prediction tools; by its position in a specific highly conserved protein region; and especially by its position in a place where another pathogenic variant has already been described (p.Glu1755Lys).
In conclusion, we identified a novel missense variant of alpha-1A subunit of the voltage-dependent P/Q-type calcium channel in a Slovak three-generation family with recurrent episodes of ataxia. The heterozygous missense variant p.Glu1755Gly resulted in changing a highly conserved glutamic acid within the pore loop of domain IV.
ABBREVIATIONS
CACNA1A, Calcium voltage-gated channel subunit alpha1 A gene; EA, Episodic ataxia; EA2, Episodic ataxia type 2; FHM1, Familial hemiplegic migraine type 1; Glu, Glutamic acid; Gly, Glycine; Lys, Lysine; PCR, Polymerase chain reaction; SCA6, Spinocerebellar ataxia type 6. Unk -unknown, n -number, Glu -glutamic acid, Gly -glycine, Lys -lysine
